,"This is a citation overview for a set of 324 documents.",,,,,,,,,,,
,,,,,,,,,,,,
,"h index = 39 (Of the 324 documents considered for the h-Index, 39 have been cited at least 39 times.)",,,,,,,,,,,
,Note: Scopus does not have complete citation information for articles published before 1996.  ,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,<2007,2007,2008,subtotal,>2008,total
Publication Year,Document Title,Authors,ISSN,Journal Title,Volume,Issue,4064,402,475,877,303,5244
2009,"Influence of operating parameters on the biodegradation of steroid estrogens and nonylphenolic compounds during biological wastewater treatment processes","Koh Y.K.K., Chiu T.Y., Boobis A.R., Scrimshaw M.D., Bagnall J.P., Soares A., Pollard S., Cartmell E., Lester J.N.",0013936X,"Environmental Science and Technology",43, 17,0,0,0,0,0,0
2009,"Increased expression of histone proteins during estrogen-mediated cell proliferation","Zhu Z., Edwards R.J., Boobis A.R.",00916765,"Environmental Health Perspectives",117, 6,0,0,0,0,0,0
2009,"The significance of sample mass in the analysis of steroid estrogens in sewage sludges and the derivation of partition coefficients in wastewaters","Chiu T.Y., Koh Y.K.K., Paterakis N., Boobis A.R., Cartmell E., Richards K.H., Lester J.N., Scrimshaw M.D.",00219673,"Journal of Chromatography A",1216, 24,0,0,0,0,1,1
2008,"Defective spermatogenesis: Martin et al. respond","Martin O.V., Shialis T., Boobis A.R., Voulvoulis N., Lester J.N., Scrimshaw M.D.",00916765,"Environmental Health Perspectives",116, 8,0,0,0,0,0,0
2008,"Re: Guyton, Kathryn Z., Barone, Stanley, Jr., Brown, Rebecca C., Euling, Susan Y., Jinot, Jennifer, Makris, Susan (2008). Mode of action frameworks: A critical analysis. Journal of Toxicology and Environmental Health, Part B, 11(1): 16-31","Meek M.E., Berry C., Boobis A.R., Cohen S.M., Hartley M., Munn S., Olin S., Schlatter J., Vickers C.",10937404,"Journal of Toxicology and Environmental Health - Part B: Critical Reviews",11, 8,0,0,0,0,0,0
2008,"Proteomic analysis of human breast cell lines using SELDI-TOF MS shows that mixtures of estrogenic compounds exhibit simple similar action (concentration additivity)","Zhu Z., Edwards R.J., Boobis A.R.",03784274,"Toxicology Letters",181, 2,0,0,0,0,1,1
2008,"Testicular dysgenesis syndrome and the estrogen hypothesis: A quantitative meta-analysis*","Martin O., Shialis T., Lester J., Scrimshaw M., Boobis A., Voulvoulis N.",14138123,"Ciencia e Saude Coletiva",13, 5,0,0,0,0,0,0
2008,"Local kinetics and dynamics of xenobiotics","Pelkonen O., Kapitulnik J., Gundert-Remy U., Boobis A.R., Stockis A.",10408444,"Critical Reviews in Toxicology",38, 8,0,0,1,1,4,5
2008,"A sensitive and robust method for the determination of alkylphenol polyethoxylates and their carboxylic acids and their transformation in a trickling filter wastewater treatment plant","Koh Y.K.K., Chiu T.Y., Boobis A.R., Cartmell E., Pollard S.J.T., Scrimshaw M.D., Lester J.N.",00456535,"Chemosphere",73, 4,0,0,0,0,3,3
2008,"Cumulative risk assessment of pesticide residues in food","Boobis A.R., Ossendorp B.C., Banasiak U., Hamey P.Y., Sebestyen I., Moretto A.",03784274,"Toxicology Letters",180, 2,0,0,0,0,3,3
2008,"Identification of estrogen-responsive proteins in MCF-7 human breast cancer cells using label-free quantitative proteomics","Zhu Z., Boobis A.R., Edwards R.J.",16159853,"Proteomics",8, 10,0,0,2,2,2,4
2008,"Treatment and removal strategies for estrogens from wastewater","Koh Y.K.K., Chiu T.Y., Boobis A., Cartmell E., Scrimshaw M.D., Lester J.N.",09593330,"Environmental Technology",29, 3,0,0,0,0,3,3
2008,"IPCS framework for analyzing the relevance of a noncancer mode of action for humans","Boobis A.R., Doe J.E., Heinrich-Hirsch B., Meek M.E., Munn S., Ruchirawat M., Schlatter J., Seed J., Vickers C.",10408444,"Critical Reviews in Toxicology",38, 2,0,0,6,6,6,12
2008,"Testicular dysgenesis syndrome and the estrogen hypothesis: A quantitative meta-analysis","Martin O.V., Shialis T., Lester J.N., Scrimshaw M.D., Boobis A.R., Voulvoulis N.",00916765,"Environmental Health Perspectives",116, 2,0,0,4,4,3,7
2007,"Physiologically-based kinetic modelling (PBK modelling): Meeting the 3Rs agenda. The report and recommendations of ECVAM workshop 63","Bouvier D'Yvoire M., Hartung T., Jacobs M.N., Lave T., Leahy D.E., Lennernas H., Loizou G.D., Meek B., Pease C., Rowland M., Spendiff M., Prieto P., Yang J., Zeilmaker M., Blaauboer B.J., Bois F.Y., Boobis A., Brochot C., Coecke S., Freidig A., Gundert-Remy U.",02611929,"ATLA Alternatives to Laboratory Animals",35, 6,0,0,2,2,2,4
2007,"Discussion","Russell R.M., Coates P.M., Scott J.M., Aggett P.J., Azzi A., Boobis A.R., Yetley E.A., Halliwell B., Przyrembel H., Eu L.Y., Taylor C.L., Rayman M., Katan M.B., Ernst E.",15282511,"Novartis Foundation Symposium",282, ,0,0,0,0,0,0
2007,"Discussion","Rayman M., Ernst E., Scott J.M., Aggett P.J., Wharton B., Taylor C.L., Yetley E.A., Boobis A.R., Halliwell B., Katan M.B.",15282511,"Novartis Foundation Symposium",282, ,0,0,0,0,0,0
2007,"Discussion","Taylor C.L., Boobis A.R., Wharton B., Halliwell B., Yetley E.A., Ernst E., Aggett P.J., Yong E.L., Przyrembel H., Manach C., Alexander J., Katan M.B., Azzi A., Shekelle P.",15282511,"Novartis Foundation Symposium",282, ,0,0,0,0,0,0
2007,"Final discussion","Aggett P.J., Stocker R., Taylor C.L., Yetley E.A., Yong E.L., Alexander J., Azzi A., Boobis A.R., Coates P.M., Manach C., Przyrembel H., Rayman M., Scott J.M.",15282511,"Novartis Foundation Symposium",282, ,0,0,0,0,0,0
2007,"Discussion","Aggett P.J., Alexander J., Boobis A.R., Przyrembel H., Scott J.M., Stocker R., Taylor C.L., Yetley E.A.",15282511,"Novartis Foundation Symposium",282, ,0,0,0,0,0,0
2007,"Discussion","Katan M.B., Halliwell B., Aggett P.J., Stocker R., Azzi A., Manach C., Boobis A.R., Russell R.M.",15282511,"Novartis Foundation Symposium",282, ,0,0,0,0,0,0
2007,"Risk assessment of dietary supplements","Boobis A.R.",15282511,"Novartis Foundation Symposium",282, ,0,0,0,0,1,1
2007,"Discussion","Azzi A., Halliwell B., Boobis A.R., Taylor C.L., Katan M.B., Yetley E.A., Aggett P.J.",15282511,"Novartis Foundation Symposium",282, ,0,0,0,0,0,0
2007,"Discussion","Azzi A., Taylor C.L., Shekelle P., Ernst E., Przyrembel H., Coates P.M., Wharton B., Aggett P.J., Russell R.M., Scott J.M., Yetley E.A., Halliwell B., Rayman M., Boobis A.R., Katan M.B., Cashman K.D.",15282511,"Novartis Foundation Symposium",282, ,0,0,0,0,0,0
2007,"Discussion","Aggett P.J., Yong E.L., Azzi A., Boobis A.R., Coates P.M., Klein M., Russell R.M., Scott J.M., Shekelle P., Yetley E.A.",15282511,"Novartis Foundation Symposium",282, ,0,0,0,0,0,0
2007,"Determination of steroid estrogens in wastewater by high performance liquid chromatography-tandem mass spectrometry","Koh Y.K.K., Chiu T.Y., Boobis A., Cartmell E., Lester J.N., Scrimshaw M.D.",00219673,"Journal of Chromatography A",1173, 1-2,0,0,6,6,9,15
2007,"Searching for novel biomarkers of centrally and peripehrally-acting neurotoxicants, using surface-enhanced laser desorption/ionisation-time-of-flight mass spectrometry (SELDI-TOF MS)","Fang M., Boobis A.R., Edwards R.J.",02786915,"Food and Chemical Toxicology",45, 11,0,0,0,0,0,0
2007,"Human health and endocrine disruption: A simple multicriteria framework for the qualitative assessment of end point-specific risks in a context of scientific uncertainty","Martin O.V., Lester J.N., Voulvoulis N., Boobis A.R.",10966080,"Toxicological Sciences",98, 2,0,0,6,6,2,8
2007,"C-terminal antibodies (CTAbs): A simple and broadly applicable approach for the rapid generation of protein-specific antibodies with predefined specificity","Edwards R.J., Sriskandan S., Wrigley A., Bai Z., Bateman M., Russell H., Murray S., Lu H., Taylor G.W., Boobis A.R.",16159853,"Proteomics",7, 9,0,0,1,1,0,1
2007,"Expression of cytochromes P450 3A and P-glycoprotein in human large intestinse in paired tumour and normal samples","Canaparo R., Nordmark A., Finnstrom N., Lundgren S., Seidegard J., Jeppsson B., Edwards R.J., Boobis A.R., Rane A.",17427835,"Basic and Clinical Pharmacology and Toxicology",100, 4,0,0,2,2,1,3
2007,"Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: Reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver","Barter Z.E., Pelkonen O.R., Tucker G.T., Rostami-Hodjegan A., Bayliss M.K., Beaune P.H., Boobis A.R., Carlile D.J., Edwards R.J., Houston J.B., Lake B.G., Lipscomb J.C.",13892002,"Current Drug Metabolism",8, 1,0,9,12,21,16,37
2006,"4-Aminobiphenyl and DNA reactivity: Case study within the context of the 2006 IPCS human relevance framework for analysis of a cancer mode of action for humans","Cohen S.M., Boobis A.R., Meek M.E., Preston R.J., McGregor D.B.",10408444,"Critical Reviews in Toxicology",36, 10,0,1,3,4,0,4
2006,"IPCS framework for analyzing the relevance of a cancer mode of action for humans","Boobis A.R., Cohen S.M., Dellarco V., McGregor D., Meek M.E., Vickers C., Willcocks D., Farland W.",10408444,"Critical Reviews in Toxicology",36, 10,1,2,20,22,13,36
2006,"Thiazopyr and thyroid disruption: Case study within the context of the 2006 IPCS human relevance framework for analysis of a cancer mode of action","Dellarco V.L., McGregor D., Berry C., Cohen S.M., Boobis A.R.",10408444,"Critical Reviews in Toxicology",36, 10,0,0,2,2,1,3
2006,"Sixty-sixth meeting of the Joint FAO/WHO Expert Committee on Food Additives","Anadon A., Rojas Martinez J.L., Sanders P., Swan G.E., Wongtavatchai J., Bruno A., Cerniglia C.E., De Lourdes Costarrica M., Friedlander L.G., Iseki N., Jeong S.-H., Arnold D., Lewicki J., McEwen S., Ozawa S., Reeves P., Ritter L., Roberts G., Sheffer M., Sundlof S., Tritscher A., Wennberg A., Boobis A., Ellis R., Fernandez Suarez A., Greenlees K., MacNeil J., McLean J.G., Palermo-Neto J.",05123054,"World Health Organization - Technical Report Series",, 939,0,0,0,0,0,0
2006,"Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues","Key J., Hodgson S., Omar R.Z., Jensen T.K., Thompson S.G., Boobis A.R., Davies D.S., Elliott P.",09575243,"Cancer Causes and Control",17, 6,1,3,13,16,6,23
2006,"Assessment of uncertainty in a probabilistic model of consumer exposure to pesticide residues in food","Ferrier H., Shaw G., Nieuwenhuijsen M., Boobis A., Elliott P.",0265203X,"Food Additives and Contaminants",23, 6,0,1,4,5,1,6
2006,"Evidence for genotoxicity of pesticides in pesticide applicators: A review","Bull S., Fletcher K., Boobis A.R., Battershill J.M.",02678357,"Mutagenesis",21, 2,2,1,6,7,7,16
2006,"Determination of a human hepatic microsomal scaling factor for predicting in vivo drug clearance","Hakooz N., Houston J.B., Ito K., Rawden H., Gill H., Lemmers L., Boobis A.R., Edwards R.J., Carlile D.J., Lake B.G.",07248741,"Pharmaceutical Research",23, 3,1,7,3,10,3,14
2006,"Agricultural chemical safety assessment: A multisector approach to the modernization of human safety requirements","Carmichael N.G., Pastoor T.P., Barton H.A., Boobis A.R., Cooper R.L., Dellarco V.L., Doerrer N.G., Fenner-Crisp P.A., Doe J.E., Lamb IV J.C.",10408444,"Critical Reviews in Toxicology",36, 1,3,0,0,0,4,7
2006,"Mode of action in relevance of rodent liver tumors to human cancer risk","Holsapple M.P., Pitot H.C., Cohen S.H., Boobis A.R., Klaunig J.E., Pastoor T., Dellarco V.L., Dragan Y.P.",10966080,"Toxicological Sciences",89, 1,5,6,12,18,7,30
2006,"A tiered approach to systemic toxicity testing for agricultural chemical safety assessment","Doe J.E., McConnell E.E., Mercier T., Moretto A., Nolan C., Padilla S., Tilbury L., Phang W., Solecki R., Van Ravenzwaay B., Wolf D.C., Boobis A.R., Blacker A., Dellarco V., Doerrer N.G., Franklin C., Goodman J.I., Kronenberg J.M., Lewis R.",10408444,"Critical Reviews in Toxicology",36, 1,3,1,3,4,3,10
2005,"No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPAR? and PPAR? act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinoma","McGreavey L.E., Garner R.C., Gooderham N., Lightfoot T., Sachse C., Waxman R., Turner F., Smith G., Boylan K., Bishop D.T., Forman D., Wolf C.R., Barrett J.H., Boobis A.R.",17446872,"Pharmacogenetics and Genomics",15, 10,4,4,5,9,2,15
2005,"Positron emission tomography in the quantification of cellular and biochemical responses to intrapulmonary particulates","Jones H.A., Hamacher K., Clark J.C., Schofield J.B., Krausz T., Haslett C., Boobis A.R.",0041008X,"Toxicology and Applied Pharmacology",207, 2,2,0,1,1,1,4
2005,"CYP3A7 protein expression is high in a fraction of adult human livers and partially associated with the CYP3A7*1C allele","Sim S.C., Edwards R.J., Boobis A.R., Ingelman-Sundberg M.",17446872,"Pharmacogenetics and Genomics",15, 9,5,5,6,11,1,17
2005,"Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertension","Paul G.A., Gibbs J.S.R., Boobis A.R., Abbas A., Wilkins M.R.",03065251,"British Journal of Clinical Pharmacology",60, 1,25,13,19,32,8,65
2005,"An approach to investigating the importance of high potency polycyclic aromatic hydrocarbons (PAHs) in the induction of lung cancer by air pollution","Okona-Mensah K.B., Battershill J., Boobis A., Fielder R.",02786915,"Food and Chemical Toxicology",43, 7,1,5,6,11,2,14
2005,"Molecular approaches to the identification of biomarkers of exposure and effect - Report of an expert meeting organized by COST Action B15","Gundert-Remy U., Dahl S.G., Boobis A., Kremers P., Kopp-Schneider A., Oberemm A., Renwick A., Pelkonen O.",03784274,"Toxicology Letters",156, 2,3,6,1,7,1,11
2005,"Action COST B15: Modelling during drug development - October 1998 to July 2004","Nitsche V., Kuhlmann J., Macheras P., Kapitulnik J., Pacifici G.-M., Danhof M., Jonkman J.H.G., Dahl S.G., Guimaraes Morais J.A., Mircioiu C., Voicu V., Kremers P., Durisova M., Benitez J., Troconiz I.F., Alvan G., Karlsson M., Balant L.P., Steimer J.-L., Yasar U., Aarons L.J., Boobis A.R., Van Peer A., Pithan K., Pascu M., Martinkova J., Brosen K., Pelkonen O., Mentre F., Paintaud G., Gundert - Remy U.",17427835,"Basic and Clinical Pharmacology and Toxicology",96, 3,0,0,0,0,0,0
2005,"Genetic and other sources of variation in the activity of serum paraoxonase/diazoxonase in humans: Consequences for risk from exposure to diazinon","O'Leary K.A., Edwards R.J., Town M.M., Boobis A.R.",0960314X,"Pharmacogenetics and Genomics",15, 1,1,4,2,6,3,10
2004,"Evaluation of certain veterinary drug residues in food","Arnold D., Moulin G., Palermo-Neto J., Rojas Martinez J.L., Soback S., Boobis A.R., Ellis R., Fernandez Suarez A., Greenlees K., Kinabo L.D.B., MacNeil J., McLean J.G., Mitema E.S.",05123054,"World Health Organization - Technical Report Series",, 925,0,0,0,0,0,0
2004,"Cruciferous vegetable consumption alters the metabolism of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in humans","Walters D.G., Young P.J., Agus C., Knize M.G., Boobis A.R., Gooderham N.J., Lake B.G.",01433334,"Carcinogenesis",25, 9,8,6,5,11,5,24
2004,"Approaches to carcinogenic risk assessment for polycyclic aromatic hydrocarbons: A UK perspective","Pufulete M., Battershill J., Boobis A., Fielder R.",02732300,"Regulatory Toxicology and Pharmacology",40, 1,3,1,3,4,2,9
2004,"Urinary N2-(2?-deoxyguanosin-8-yl)PhIP as a biomarker for PhIP exposure","Fang M., Edwards R.J., Bartlet-Jones M., Taylor G.W., Murray S., Boobis A.R.",01433334,"Carcinogenesis",25, 6,3,1,0,1,0,4
2003,"Expression of CYP3A4 in human breast tumour and non-tumour tissues","Kapucuoglu N., Coban T., Raunio H., Pelkonen O., Edwards R.J., Boobis A.R., Iscan M.",03043835,"Cancer Letters",202, 1,5,2,2,4,0,9
2003,"A strategy for investigating the CYP superfamily using targeted antibodies is a paradigm for functional genomic studies","Edwards R.J., Boobis A.R., Davies D.S.",00909556,"Drug Metabolism and Disposition",31, 12,3,2,3,5,0,8
2003,"Differential expression of cytochrome P450 enzymes in cultured and intact foetal rat ventral mesencephalon","Gilbert E.A., Edwards R.J., Boobis A.R., Rose S., Jenner P.",03009564,"Journal of Neural Transmission",110, 10,1,0,0,0,0,1
2003,"Comparative studies on the cytochrome P450-associated metabolism and interaction potential of selegiline between human liver-derived in vitro systems","Salonen J.S., Castell J.V., Ingelman-Sundberg M., Hidestrand M., Guillouzo A., Corcos L., Goldfarb P.S., Lewis D.F.V., Taavitsainen P., Pelkonen O., Nyman L., Boobis A.R., Edwards R.J., Watts P., Lake B.G., Price R.J., Renwick A.B., Gomez-Lechon M.-J.",00909556,"Drug Metabolism and Disposition",31, 9,17,8,3,11,1,29
2003,"Risk characterisation of chemicals in food and diet","Renwick A.G., Lambe J., Muller D.J.G., Smith M.R., Tritscher A., Tuijtelaars S., Van Den Brandt P.A., Walker R., Kroes R., Barlow S.M., Hertz-Picciotto I., Boobis A.R., Dybing E., Edler L., Eisenbrand G., Greig J.B., Kleiner J.",02786915,"Food and Chemical Toxicology",41, 9,31,6,11,17,5,53
2003,"Immunohistochemical demonstration of the expression of CYP2E1 in human breast tumour and non-tumour tissues","Kapucuoglu N., Coban T., Raunio H., Pelkonen O., Edwards R.J., Boobis A.R., Iscan M.",03043835,"Cancer Letters",196, 2,10,2,1,3,2,15
2003,"Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism","Westlind-Johnsson A., Malmebo S., Johansson A., Otter C., Andersson T.B., Johansson I., Edwards R.J., Boobis A.R., Ingelman-Sundberg M.",00909556,"Drug Metabolism and Disposition",31, 6,70,19,10,29,3,102
2003,"Expression of cyclooxygenase-2 parallels expression of interleukin-1beta, interleukin-6 and NF-kappaB in human colorectal cancer","Maihofner C., Forman D., Garner R.C., Sachse C., Smith G., Waxman R., Wolf C.R., Charalambous M.P., Bhambra U., Lightfoot T., Geisslinger G., Gooderham N.J., Barrett J., Bishop D.T., Boobis A.R.",01433334,"Carcinogenesis",24, 4,18,1,2,3,0,21
2003,"PET imaging of pulmonary fibrosis.","Jones H.A., Boobis A.R., Hamacher K., Coenen H.H., Clark J.C.",01615505,"Journal of nuclear medicine : official publication, Society of Nuclear Medicine",44, 3,4,1,2,3,2,9
2003,"Adduction of the chloroform metabolite phosgene to lysine residues of human histone H2B","Fabrizi L., Taylor G.W., Canas B., Boobis A.R., Edwards R.J.",0893228X,"Chemical Research in Toxicology",16, 3,5,0,1,1,0,6
2003,"Induction of cytochrome p450 enzymes in cultured precision-cut human liver slices","Edwards R.J., Price R.J., Watts P.S., Renwick A.B., Michael Tredger J., Boobis A.R., Lake B.G.",00909556,"Drug Metabolism and Disposition",31, 3,19,9,11,20,5,44
2003,"Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancer","Barrett J.H., Forman D., Boobis A.R., Colin R., Sachse C., Smith G., Waxman R., Gooderham N., Lightfoot T., Garner R.C., Augustsson K., Wolf C.R., Bishop D.T.",01433334,"Carcinogenesis",24, 2,29,6,11,17,2,48
2003,"Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: Allele frequencies, linkage disequilibrium and influence on caffeine metabolism","Sachse C., Gooderham N.J., Bishop D.T., Forman D., Waxman R., Bhambra U., Smith G., Lightfoot T.J., Barrett J.H., Scollay J., Garner R.C., Boobis A.R., Wolf C.R.",03065251,"British Journal of Clinical Pharmacology",55, 1,40,12,10,22,5,67
2002,"In silico prediction of ADME and pharmacokinetics: Report of an expert meeting organised by COST B15","Boobis A., Gundert-Remy U., Kremers P., Macheras P., Pelkonen O.",09280987,"European Journal of Pharmaceutical Sciences",17, 4-5,36,4,1,5,3,44
2002,"Evaluation of certain veterinary drug residues in food","Anadon A., Mitema E.S., Palermo-Neto J., Soback S., Stephany R.W., Arnold D., Boisseau J., Boobis A.R., Ellis R., Greenlees K., McLean J.G., MacNeil J., Rojas Martinez J.L.",05123054,"World Health Organization - Technical Report Series",, 911,0,0,0,0,0,0
2002,"The mutational signature of ?-hydroxytamoxifen at Hprt locus in Chinese hamster cells","Yadollahi-Farsani M., Davies D.S., Boobis A.R.",01433334,"Carcinogenesis",23, 11,4,0,0,0,0,4
2002,"A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer","Sachse C., Barrett J., Boobis A.R., Garner R.C., Gooderham N., Lightfoot T., Smith G., Wilkie M.J.V., Barrett J.H., Waxman R., Sullivan F., Forman D., Bishop D.T., Wolf C.R.",01433334,"Carcinogenesis",23, 11,81,20,18,38,5,124
2002,"Expression of P450 enzymes in rat whole skin and cultured epidermal keratinocytes","Zhu Z., Hotchkiss S.A., Boobis A.R., Edwards R.J.",0006291X,"Biochemical and Biophysical Research Communications",297, 1,7,2,4,6,1,14
2002,"Kinetics of lung macrophages monitored in vivo following particulate challenge in rabbits","Jones H.A., Valind S.O., Clark I.C., Bolden G.E., Krausz T., Schofield J.B., Boobis A.R., Haslett C.",0041008X,"Toxicology and Applied Pharmacology",183, 1,6,2,3,5,2,13
2002,"Current knowledge and recent developments in consumer exposure assessment of pesticides: A UK perspective","Ferrier H., Nieuwenhuijsen M., Boobis A., Elliott P.",0265203X,"Food Additives and Contaminants",19, 9,6,1,3,4,1,11
2002,"Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: Molecular mechanisms that determine lower expression in cultured cells","Rodriguez-Antona C., Donato M.T., Boobis A., Edwards R.J., Watts P.S., Castell J.V., Gomez-Lechon M.-J.",00498254,"Xenobiotica",32, 6,48,27,18,45,7,100
2002,"Basic or applied, it's the interaction that counts [1]","Farmer P.B., Swenberg J.A., Tannenbaum S.R., Wild C.P., Bartsch H., Boobis A., Chipman K., Gescher A., Kadlubar F.F., Manson M.M., Phillips D.H., Shuker D.E.G.",00280836,"Nature",417, 6885,0,0,0,0,0,0
2002,"Cancer research UK procedures in manufacture and toxicology of radiotracers intended for pre-phase I positron emission tomography studies in cancer patients","Aboagye E.O., Luthra S.K., Brady F., Poole K., Anderson H., Jones T., Boobis A., Burtles S.S., Price P.",00070920,"British Journal of Cancer",86, 7,10,0,2,2,1,13
2002,"Methods of in vitro toxicology","Eisenbrand G., Pieters R., Kleiner J., Pool-Zobel B., Baker V., Balls M., Blaauboer B.J., Boobis A., Carere A., Kevekordes S., Lhuguenot J.-C.",02786915,"Food and Chemical Toxicology",40, 2-3,47,16,17,33,13,93
2001,"Cytochrome P450 3A expression in the human fetal liver: Evidence that CYP3A5 is expressed in only a limited number of fetal livers","Hakkola J., Raunio H., Purkunen R., Saarikoski S., Vahakangas K., Pelkonen O., Edwards R.J., Boobis A.R., Pasanen M.",00063126,"Biology of the Neonate",80, 3,18,3,4,7,0,25
2001,"Adducts of the chloroform metabolite phosgene","Fabrizi L., Taylor G.W., Edwards R.J., Boobis A.R.",00652598,"Advances in Experimental Medicine and Biology",500, ,1,0,0,0,0,1
2001,"Diazinon is activated by CYP2C19 in human liver","Kappers W.A., Edwards R.J., Murray S., Boobis A.R.",0041008X,"Toxicology and Applied Pharmacology",177, 1,15,10,1,11,1,27
2001,"In vitro prediction of gastrointestinal absorption and bioavailability: an experts' meeting report.","Pelkonen O., Boobis A.R., Gundert-Remy U.",00316970,"European Journal of Clinical Pharmacology",57, 9,14,5,0,5,1,20
2001,"Effect of cruciferous vegetable consumption on heterocyclic aromatic amine metabolism in man","Murray S., Lake B.G., Gray S., Edwards A.J., Springall C., Bowey E.A., Williamson G., Boobis A.R., Gooderham N.J.",01433334,"Carcinogenesis",22, 9,30,3,3,6,6,42
2001,"Carbamazepine: A 'blind' assessment of CYP-associated metabolism and interactions in human liver-derived in vitro systems","Pelkonen O., Castell J.V., Ingelman-Sundberg M., Hidestrand M., Guillouzo A., Corcos L., Goldfarb P.S., Lewis D.F.V., Myllynen P., Taavitsainen P., Boobis A.R., Watts P., Lake B.G., Price R.J., Renwick A.B., Gomez-Lechon M.-J.",00498254,"Xenobiotica",31, 6,20,3,6,9,2,31
2001,"Evaluation of certain veterinary drug residues in food","Anadon A., Palermo-Neto J., Rojas Martinez J.L., Soback S., Stephany R.W., Appelgren L.-E., Arnold D., Boisseau J., Boobis A.R., Kinabo L.D.B., McLean J.G., MacNeil J.D., Miller M.A.",05123054,"World Health Organization - Technical Report Series",, 900,0,0,0,0,0,0
2001,"Inhibition of human CYP1A2 activity in vitro by methylxanthines: Potent competitive inhibition by 8-phenyltheophylline","Murray S., Odupitan A.O.A., Murray B.P., Boobis A.R., Edwards R.J.",00498254,"Xenobiotica",31, 3,7,0,1,1,0,8
2001,"An assessment of human liver-derived in vitro systems to predict the in vivo metabolism and clearance of almokalant","Andersson T.B., Gomez-Lechon M.J., Castell J.V., Ingelman-Sundberg M., Hidestrand M., Goldfarb P.S., Lewis D.F.V., Corcos L., Guillouzo A., Taavitsainen P., Pelkonen O., Sjoberg H., Hoffmann K.-J., Boobis A.R., Watts P., Edwards R.J., Lake B.G., Price R.J., Renwick A.B.",00909556,"Drug Metabolism and Disposition",29, 5,24,5,2,7,1,32
2001,"Food-derived heterocyclic amine mutagens: Variable metabolism and significance to humans","Gooderham N.J., Murray S., Lynch A.M., Yadollahi-Farsani M., Zhao K., Boobis A.R., Davies D.S.",00909556,"Drug Metabolism and Disposition",29, 4,13,1,2,3,3,19
2001,"Toxicology Letters: Preface","Boobis A.R.",03784274,"Toxicology Letters",120, 1-3,0,0,0,0,0,0
2001,"Assessment of P450 induction in the marmoset monkey using targeted anti-peptide antibodies","Schulz T.G., Thiel R., Neubert D., Brassil P.J., Schulz-Utermoehl T., Boobis A.R., Edwards R.J.",01674838,"Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology",1546, 1,6,0,0,0,0,6
2000,"Expression and distribution of CYP2C enzymes in rat basal ganglia","Riedl A.G., Watts P.M., Douek D.C., Edwards R.J., Boobis A.R., Rose S., Jenner P.",08874476,"Synapse",38, 4,7,0,0,0,1,8
2000,"Evaluation of certain veterinary drug residues in food","Appelgren L.-E., MacNeil J.D., Miller M.A., Mitema E.S., Montes Nino A.M., Palermo-Neto J., Shojaee AliAbadi F., Stephany R.W., Cerniglia C.E., Franceschi S., Gaylor D.W., Arnold D., Heitzman R.J., Herrman J.L., Leighton J., Livingston R.C., McGregor D.B., Mitsumori K., Morgan M.R.A., Olsen P., Pronk M.E.W., Ritter L., Baggot J.D., Roestel B., Soback S., Sundlof S., Ungemach F.R., Weatherwax J., Weber N., Wells R., Zmudski J., Boisseau J., Boobis A.R., Boorman G., Ellis R.L., Kinabo L.D.B., McLean J.G.",05123054,"World Health Organization - Technical Report Series",, 893,0,0,0,0,0,0
2000,"Differential maintenance of cytochrome P450 enzymes in cultured precision-cut human liver slices","Renwick A.B., Lake B.G., Watts P.S., Edwards R.J., Barton P.T., Guyonnet I., Price R.J., Tredger J.M., Pelkonen O., Boobis A.R.",00909556,"Drug Metabolism and Disposition",28, 10,21,6,6,12,2,35
2000,"Mass spectrometric detection and measurement of N2-(2'-deoxyguanosin-8-yl)PhIP adducts in DNA","Crosbie S.J., Murray S., Boobis A.R., Gooderham N.J.",13872273,"Journal of Chromatography B: Biomedical Sciences and Applications",744, 1,9,4,2,6,0,15
2000,"Expression of CYP1A1, CYP1B1 and CYP3A, and polycyclic aromatic hydrocarbon-DNA adduct formation in bronchoalveolar macrophages of smokers and non-smokers","Piipari R., Boobis A.R., Anttila S., Savela K., Nurminen T., Hukkanen J., Raunio H., Hakkola J., Mantyla T., Beaune P., Edwards R.J.",00207136,"International Journal of Cancer",86, 5,41,3,6,9,1,51
2000,"Affinity and potency of proinhibitory antipeptide antibodies against CYP2D6 is enhanced using cyclic peptides as immunogens","Schulz-Utermoehl T., Edwards R.J., Boobis A.R.",00909556,"Drug Metabolism and Disposition",28, 5,9,0,1,1,0,10
2000,"The food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine activates S-phase checkpoint and apoptosis, and induces gene mutation in human lymphoblastoid TK6 cells","Zhu H., Boobis A.R., Gooderham N.J.",00085472,"Cancer Research",60, 5,14,1,1,2,0,16
1999,"Hepatic metabolism of diclofenac: Role of human CYP in the minor oxidative pathways","Bort R., MacE K., Boobis A., Gomez-Lechon M.-J., Pfeifer A., Castell J.",00062952,"Biochemical Pharmacology",58, 5,59,13,6,19,7,85
1999,"Polymorphic debrisoquine 4-hydroxylase activity in the rat is due to differences in CYP2D2 expression","Schulz-Utermoehl T., Bennett A.J., Ellis S.W., Tucker G.T., Boobis A.R., Edwards R.J.",0960314X,"Pharmacogenetics",9, 3,26,1,1,2,0,28
1999,"Evaluation of certain veterinary drug residues in food","Appelgren L.-E., Mitema E.S., Palermo-Neto J., Pinter A., Rojas Martinez J.L., Sinhaseni P., Soback S., Wells R., Cerniglia C.E., Chamberlain P., Chernausek S.D., Arnold D., Fuchs R., Good E.A.M., Hansen M.K., Heitzman R.J., Herrman J.L., Mitsumori K., Nord C.E., Olsen P., Paakkanen J., Pronk M.E.J., Boisseau J., Ritter L., Roberts G., Roestel B., Sills R.C., Sundlof S., Ungemach F.R., Weber N., Boobis A.R., Ellis R.L., Livingston R.C., McLean J.G., MacNeil J.D., Miller M.A.",05123054,"World Health Organization - Technical Report Series",, 888,0,0,0,0,0,0
1999,"Expression of xenobiotic-metabolizing CYPs in human pulmonary tissue","Raunio H., Edwards R.J., Hakkola J., Hukkanen J., Lassila A., Paivarinta K., Pelkonen O., Anttila S., Piipari R., Boobis A.",09402993,"Experimental and Toxicologic Pathology",51, 4-5,34,2,8,10,0,44
1999,"Expression and localisation of CYP2D enzymes in rat basal ganglia","Riedl A.G., Watts P.M., Edwards R.J., Schulz-Utermoehl T., Boobis A.R., Jenner P., Marsden C.D.",00068993,"Brain Research",822, 1-2,14,0,1,1,0,15
1999,"The mutagenicity of benzo[a]pyrene in mouse small intestine","Brooks R.A., Gooderham N.J., Edwards R.J., Boobis A.R., Winton D.J.",01433334,"Carcinogenesis",20, 1,14,2,0,2,1,17
1998,"Genetic analysis of PHIP intestinal mutations in Muta®Mouse","Lynch A.M., Gooderham N.J., Davies D.S., Boobis A.R.",02678357,"Mutagenesis",13, 6,21,0,0,0,0,21
1998,"Pulmonary fibrosis correlates with duration of tissue neutrophil activation","Jones H.A., Schofield J.B., Krausz T., Boobis A.R., Haslett C.",1073449X,"American Journal of Respiratory and Critical Care Medicine",158, 2,34,6,3,9,3,46
1998,"Development of a comprehensive panel of antibodies against the major xenobiotic metabolising forms of cytochrome P450 in humans","Edwards R.J., Adams D.A., Watts P.S., Davies D.S., Boobis A.R.",00062952,"Biochemical Pharmacology",56, 3,76,5,5,10,3,89
1998,"Comparative physicochemical and pharmacokinetic profiles of inhaled beclomethasone dipropionate and budesonide","Boobis A.R.",09546111,"Respiratory Medicine",92, ,16,3,0,3,2,21
1998,"Interlaboratory comparison of the assessment of P450 activities in human hepatic microsomal samples","Boobis A.R., McKillop D., Robinson D.T., Adams D.A., McCormick D.J.",00498254,"Xenobiotica",28, 5,15,4,1,5,0,20
1998,"Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylase","Watts P.M., Riedl A.G., Douek D.C., Edwards R.J., Boobis A.R., Jenner P., Marsden C.D.",03064522,"Neuroscience",86, 2,19,1,4,5,2,26
1998,"Expression of xenobiotic-metabolizing cytochrome P450s in human pulmonary tissues.","Raunio H., Hakkola J., Hukkanen J., Pelkonen O., Edwards R., Boobis A., Anttila S.",01719750,"Archives of toxicology. Supplement. = Archiv für Toxikologie. Supplement",20, ,35,1,1,2,2,39
1998,"Food-derived heterocyclic amines induce a spectrum of mutations which are diagnostic of their mutagenicity","Lynch A.M., Gooderham N.J., Davies D.S., Boobis A.R.",02678357,"Mutagenesis",13, 3,1,0,0,0,0,1
1997,"Expression and Localization of CYP3A4 and CYP3A5 in Human Lung","Anttila S., Hukkanen J., Hakkola J., Stjernvall T., Beaune P., Edwards R.J., Boobis A.R., Pelkonen O., Raunio H.",10441549,"American Journal of Respiratory Cell and Molecular Biology",16, 3,73,5,4,9,1,83
1997,"Expression and inducibility of p450 enzymes during liver ontogeny","Rich K.J., Boobis A.R.",1059910X,"Microscopy Research and Technique",39, 5,23,8,6,14,2,39
1997,"BTS working party report on in vitro toxicology","Fielder R.J., Lumley C.E., Kimber I., Newall D.R., Atterwill C.K., Anderson D., Boobis A.R., Botham P., Chamberlain M., Combes R., Duffy P.A., Lewis R.W.",09603271,"Human and Experimental Toxicology",16, 1,11,0,3,3,0,14
1997,"The cardiac effects of terfenadine after inhibition of its metabolism by grapefruit juice","Clifford C.P., Adams D.A., Murray S., Taylor G.W., Wilkins M.R., Boobis A.R., Davies D.S.",00316970,"European Journal of Clinical Pharmacology",52, 4,35,2,3,5,0,40
1997,"Specific inhibition of human CYP1A2 using a targeted antibody","Adams D.A., Edwards R.J., Davies D.S., Boobis A.R.",00062952,"Biochemical Pharmacology",54, 1,9,0,0,0,0,9
1997,"Assessing human risk to heterocyclic amines","Gooderham N.J., Murray S., Lynch A.M., Yadollahi-Farsani M., Zhao K., Rich K., Boobis A.R., Davies D.S.",00275107,"Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis",376, 1-2,27,0,0,0,1,28
1997,"Dissociation of neutrophil emigration and metabolic activity in lobar pneumonia and bronchiectasis","Jones H.A., Sriskandan S., Peters A.M., Pride N.B., Krausz T., Boobis A.R., Haslett C.",09031936,"European Respiratory Journal",10, 4,41,9,5,14,6,61
1997,"Evidence for nitric oxide participation in down-regulation of CYP2B1/2 gene expression at the pretranslational level","Khatsenko O.G., Boobis A.R., Gross S.S.",03784274,"Toxicology Letters",90, 2-3,26,1,2,3,3,32
1996,"Selective localisation of P450 enzymes and NADPH-P450 oxidoreductase in rat basal ganglia using anti-peptide antisera","Riedl A.G., Watts P.M., Edwards R.J., Boobis A.R., Jenner P., Marsden C.D.",00068993,"Brain Research",743, 1-2,21,1,4,5,2,28
1996,"Interindividual variability in metabolic activation in humans in vivo","Boobis A.R.",13826689,"Environmental Toxicology and Pharmacology",2, 2-3,2,0,0,0,0,2
1996,"Organ distinctive mutagenicity in Muta®Mouse after short-term exposure to PhIP","Lynch A.M., Gooderham N.J., Boobis A.R.",02678357,"Mutagenesis",11, 5,16,0,0,0,0,16
1996,"Chemical methods for assessing systemic exposure to dietary heterocyclic amines in man.","Davies D.S., Gooderham N.J., Murray S., Lynch A., de la Torre R., Segura J., Boobis A.R.",01719750,"Archives of toxicology. Supplement. = Archiv für Toxikologie. Supplement",18, ,3,0,0,0,0,3
1996,"Enzymic and interindividual differences in the human metabolism of heterocyclic amines.","Boobis A.R., Gooderham N.J., Edwards R.J., Murray S., Lynch A.M., Yadollahi-Farsani M., Davies D.S.",01719750,"Archives of toxicology. Supplement. = Archiv für Toxikologie. Supplement",18, ,15,1,0,1,0,16
1996,"Heterocyclic amines: Evaluation of their role in diet associated human cancer","Gooderham N.J., Bhadresa S., Crosbie S.J., Boobis A.R., Davies D.S., Murray S., Lynch A.M., Edwards R.J., Yadollahi-Farsani M., Bratt C., Rich K.J., Zhao K., Murray B.P.",03065251,"British Journal of Clinical Pharmacology",42, 1,28,2,0,2,2,32
1996,"Dissecting the function of cytochrome p450","Boobis A.R., Edwards R.J., Adams D.A., Davies D.S.",03065251,"British Journal of Clinical Pharmacology",42, 1,19,1,1,2,0,21
1996,"Mutational spectra of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) at the Chinese hamster hprt locus","Yadollahi-Farsani M., Gooderham N.J., Davies D.S., Boobis A.R.",01433334,"Carcinogenesis",17, 4,49,2,0,2,0,51
1996,"Developmental changes in hepatic activation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rabbit","Rich K.J., Zhao K., Davies D.S., Boobis A.R., Gooderham N.J.",01433334,"Carcinogenesis",17, 3,4,0,0,0,0,4
1996,"Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta","Hakkola J., Pasanen M., Hukkanen J., Pelkonen O., Maenpaa J., Edwards R.J., Boobis A.R., Raunio H.",00062952,"Biochemical Pharmacology",51, 4,90,6,4,10,6,106
1995,"Exposure to and activation of dietary heterocyclic amines in humans","Lynch A.M., Murray S., Gooderham N.J., Boobis A.R.",10408428,"Critical Reviews in Oncology/Hematology",21, 1-3,9,0,0,0,0,9
1995,"Systemic exposure to dietary heterocyclic amines in man.","Davies D.S., Gooderham N.J., Murray S., Lynch A., de la Torre R., Segura J., Boobis A.R.",,"Princess Takamatsu symposia",23, ,2,1,0,1,0,3
1995,"Distribution and induction of CYP3A1 and CYP3A2 in rat liver and extrahepatic tissues","Debri K., Boobis A.R., Davies D.S., Edwards R.J.",00062952,"Biochemical Pharmacology",50, 12,65,2,2,4,4,73
1995,"Enzymatic studies of the activation of heterocyclic food mutagens in man.","Boobis A.R., Gooderham N.J., Rich K.J., Zhao K., Edwards R.J., Murray B.P., Lynch A.M., Murray S., Davies D.S.",,"Princess Takamatsu symposia",23, ,8,0,0,0,0,8
1995,"Short synthetic peptides exploited for reliable and specific targeting of antibodies to the C-termini of cytochrome P450 enzymes","Edwards R.J., Singleton A.M., Murray B.P., Davies D.S., Boobis A.R.",00062952,"Biochemical Pharmacology",49, 1,39,2,1,3,1,43
1994,"Should breast feeding mothers give up meat? Metabolism of the food-derived carcinogen 2-amino-1-methyl-6-phenyl-imidazo [4,5-b] pyridine by lactating Fischer 344 rats and their nursing pups.","Boobis A.R.",09603271,"Human & experimental toxicology",13, 12,0,0,0,0,0,0
1994,"Preface","Boobis A.R.",08872333,"Toxicology in Vitro",8, 4,0,0,0,0,0,0
1994,"Metabolism of the food derived mutagen and carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) by human liver microsomes","Zhao K., Murray S., Davies D.S., Boobis A.R., Gooderham N.J.",01433334,"Carcinogenesis",15, 6,46,2,1,3,1,50
1994,"Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human","Edwards R.J., Murray B.P., Murray S., Schulz T., Neubert D., Gant T.W., Thorgeirsson S.S., Boobis A.R., Davies D.S.",01433334,"Carcinogenesis",15, 5,89,1,5,6,0,95
1994,"2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine is a potent mutagen in the mouse small intestine","Brooks R.A., Gooderham N.J., Zhao K., Edwards R.J., Howard L.A., Boobis A.R., Winton D.J.",00085472,"Cancer Research",54, 7,32,1,0,1,0,33
1994,"The 'Register of Toxicologists'","Fowler J., Jackson M., Boobis A.",01445952,"Human and Experimental Toxicology",13, 6,5,0,0,0,0,5
1994,"The role of CYP1A enzymes in murine activation of the cooked food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine","Zhao K., Boobis A.R., Davies D.S., Gooderham N.J.",03005127,"Biochemical Society Transactions",22, 2,0,0,0,0,0,0
1994,"The practical applicability of hepatocyte cultures in routine testing. The report and recommendations of ECVAM workshop 1","Blaauboer B.J., Miltenburger H.G., Rogiers V., Skett P., Villa P., Wiebel F.J., Boobis A.R., Castell J.V., Coecke S., Groothuis G.M.M., Guillouzo A., Hall T.J., Hawksworth G.M., Lorenzon G.",02611929,"ATLA (ALTERN.LAB.ANIM.)",22, 4,52,1,3,4,2,58
1994,"CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans","Boobis A.R., Lynch A.M., Murray S., De La Torre R., Solans A., Farre M., Segura J., Gooderham N.J., Davies D.S.",00085472,"Cancer Research",54, 1,142,6,9,15,7,164
1993,"Identification of the epitope of an anti-peptide antibody which binds to CYP1A2 in many species including man","Edwards R.J., Murray B.P., Singleton A.M., Murray S., Davies D.S., Boobis A.R.",00062952,"Biochemical Pharmacology",46, 2,28,0,0,0,1,29
1993,"An inhibitory monoclonal anti-protein antibody and an anti-peptide antibody share an epitope on rat cytochrome P-450 enzymes CYP1A1 and CYP1A2","Edwards R.J., Murray B.P., Murray S., Singleton A.M., Davies D.S., Boobis A.R.",01674838,"Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology",1161, 1,9,0,0,0,0,9
1993,"Report of the BTS/UKEMS working group on dose setting in In-Vivo mutagenicity assays","Fielder R.J., Kirkland D.J., Richold M., Allen J.A., Boobis A.R., Botham P.A., Doe J., Esdaile D.J., Gatehouse D.G., Hodson-Walker G., Morton D.B.",01445952,"Human and Experimental Toxicology",12, 3,1,0,0,0,1,2
1993,"Human hepatic CYP1A1 and CYP1A2 content, determined with specific anti-peptide antibodies, correlates with the mutagenic activation of PhIP","Murray B.P., Edwards R.J., Murray S., Singleton A.M., Davies D.S., Boobis A.R.",01433334,"Carcinogenesis",14, 4,46,2,2,4,0,50
1993,"Ontogenetic development of the distribution of constitutive and 3- methylcholanthrene-induced CYP1A1 and CYP1A2 in rabbit liver","Rich K.J., Foster J.R., Edwards R.J., Davies D.S., Boobis A.R.",00221554,"Journal of Histochemistry and Cytochemistry",41, 6,8,0,0,0,0,8
1993,"Molecular dosimetry of the food-borne carcinogen MeIQx using adducts of serum albumin","Lynch A.M., Murray S., Zhao K., Gooderham N.J., Boobis A.R., Davies D.S.",01433334,"Carcinogenesis",14, 2,13,0,0,0,1,14
1993,"Conservation of a functionally important surface region between two families of the cytochrome P-450 superfamily [1]","Murray B.P., Edwards R.J., Davies D.S., Boobis A.R.",02646021,"Biochemical Journal",292, 1,3,0,0,0,0,3
1993,"Correspondence re: A.M. Lynch et al., intra- and interindividual variability in systemic exposure in humans to 2-amino-3,8- dimethylimidazo[4,5-f]-quinoxaline and 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine, carcinogens present in cooked beef. Cancer Res., 52: 6216- 6223, 1992 [2]","Shubik P., Lynch A.M., Boobis A.R., Davies D.S., Murray S., Gooderham N.",00085472,"Cancer Research",53, 24,0,0,0,0,0,0
1992,"Molecular basis for differences in susceptibility to toxicants: Introduction","Boobis A.R.",03784274,"Toxicology Letters",64-65, ,5,0,1,1,0,6
1992,"Paracetamol toxicity and its prevention by cytoprotection with iloprost","Davies D.S., Fawthrop D.J., Nasseri-Sina P., Wilson J.W., Hardwick S.J., Boobis A.R.",03784274,"Toxicology Letters",64-65, ,3,0,0,0,0,3
1992,"N-hydroxy-MeIQx is the major microsomal oxidation product of the dietary carcinogen MeIQx with human liver","Rich K.J., Murray B.P., Lewis I., Rendell N.B., Davies D.S., Gooderham N.J., Boobis A.R.",01433334,"Carcinogenesis",13, 12,30,1,0,1,1,32
1992,"Paracetamol toxicity in hamster isolated hepatocytes: The increase in cytosolic calcium accompanies, rather than precedes, loss of viability","Hardwick S.J., Wilson J.W., Fawthrop D.J., Boobis A.R., Davies D.S.",03405761,"Archives of Toxicology",66, 6,8,0,0,0,0,8
1992,"Expression of CYP2E1 during human fetal development: Methylation of the CYP2E1 gene in human fetal and adult liver samples","Jones S.M., Boobis A.R., Moore G.E., Stanier P.M.",00062952,"Biochemical Pharmacology",43, 8,26,1,2,3,2,31
1992,"Identification of the epitope of a monoclonal antibody which binds to several cytochromes P450 in the CYP1A subfamily","Edwards R.J., Sesardic D., Murray B.P., Singleton A.M., Davies D.S., Boobis A.R.",00062952,"Biochemical Pharmacology",43, 8,6,0,0,0,0,6
1992,"Cycloheximide abolishes the cytoprotective effect of iloprost on paracetamol-treated RLER52H-16 cells","Fawthrop D.J., Wilson J., Hardwick S., Thorgeirsson S., Battula N., Boobis A.R., Davies D.S.",01445952,"Human and Experimental Toxicology",11, 5,0,0,0,0,0,0
1992,"CYP1A2 is responsible for the hepatic microsomal metabolism of MeIQx to N-hydroxy MeIQx in man","Rich K.J., Murray B.P., Gooderham N.J., Lewis I., Davies D.S., Boobis A.R.",03065251,"British Journal of Clinical Pharmacology",33, 2,0,0,0,0,0,0
1992,"Identification of N-hydroxy-MeIQx as the major product of the microsomal oxidation of MeIQx by human liver","Rich K.J., Gooderham N.J., Lewis I., Taylor G., Rendell N., Boobis A.R., Davis D.S.",01445952,"Human and Experimental Toxicology",11, 5,0,0,0,0,0,0
1992,"Disparate effects of 4-isopropyl-3,5-diethoxycarbonyl-1,4-dihydro-2,3,6-trimethylpyridine on CYP1A activities and apoprotein levels in the rat","Edwards R.J., Gilroy D.W., Murray S., Murray B.P., Boobis A.R.",03065251,"British Journal of Clinical Pharmacology",33, 2,0,0,0,0,0,0
1992,"The role of [Ca2+](i) in paracetamol toxicity: Studies in isolated hamster hepatocytes","Hardwick S.J., Wilson J.W., Fawthrop D.J., Boobis A.R., Davies D.S.",01445952,"Human and Experimental Toxicology",11, 5,0,0,0,0,0,0
1992,"Pharmacokinetics of [14C]FCE 22891, a penem antibiotic, following oral administration to healthy volunteers","Efthymiopoulos C., Benedetti M.S., Sassella D., Boobis A., Davies D.",00664804,"Antimicrobial Agents and Chemotherapy",36, 9,1,1,0,1,0,2
1992,"Potent in vitro inhibition of human CYP1A2 by pharmacologically diverse agents","Murray B.P., Lennox S.V., Murray S., Boobis A.R.",03065251,"British Journal of Clinical Pharmacology",33, 2,1,0,0,0,0,1
1992,"Cytoprotection by iloprost against paracetamol-induced toxicity in hamster isolated hepatocytes","Nasseri-Sina P., Fawthrop D.J., Wilson J., Boobis A.R., Davies D.S.",00071188,"British Journal of Pharmacology",105, 2,8,0,0,0,0,8
1992,"Intra- and interindividual variability in systemic exposure in humans to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline and 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine, carcinogens present in cooked beef","Lynch A.M., Knize M.G., Boobis A.R., Gooderham N.J., Davies D.S., Murray S.",00085472,"Cancer Research",52, 22,85,5,4,9,2,96
1992,"Report of British Toxicology Society/UK Environmental Mutagen Society Working Group. Dose setting in in vivo mutagenicity assays","Fielder R.J., Kirkland D.J., Richold M., Allen J.A., Boobis A.R., Botham P.A., Doe J., Esdaile D.J., Gatehouse D.G., Hodson-Walker G., Morton D.B.",02678357,"Mutagenesis",7, 5,4,1,1,2,0,6
1992,"Production of polyclonal antibodies which recognize MeIQx and MeIQx-protein adducts","Zhao K., Edwards R.J., Gooderham N.J., Boobis A.R., Davies D.S.",01445952,"Human and Experimental Toxicology",11, 5,0,0,0,0,0,0
1991,"Orientation of cytochromes P450 in the endoplasmic reticulum","Edwards R.J., Murray B.P., Singleton A.M., Boobis A.R.",00062960,"Biochemistry®",30, 1,21,3,0,3,1,25
1991,"Antipeptide antibodies in studies of cytochromes P450IA","Edwards R.J., Murray B.P., Boobis A.R.",00766879,"Methods in Enzymology",206, ,20,1,0,1,0,21
1991,"Absorption and disposition of MeIQx in man: lessons for human dosimetry.","Boobis A.R., Gooderham N.J., Murray B.P., Murray S., Lynch A., Sesardic D., Davies D.S.",03617742,"Progress in clinical and biological research",372, ,1,0,0,0,0,1
1991,"Distribution and elimination of [2-(14)C]Amino-3, 8-dimethylimidazo [4, 5-f] quinoxaline in mice. Analysis by whole animal autoradiography","Gooderham N.J., Soames A., Rice J.C., Boobis A.R., Davies D.S.",01445952,"Human and Experimental Toxicology",10, 5,5,0,0,0,0,5
1991,"Rapid analysis for metabolites of 11C-labelled drugs: Fate of [11C]-S-4-(tert.-butylamino-2-hydroxypropoxy)-benzimidazol-2-one in the dog","Jones H.A., Rhodes C.G., Law M.P., Becket J.M., Clark J.C., Boobis A.R., Taylor G.W.",03784347,"Journal of Chromatography - Biomedical Applications",570, 2,5,0,1,1,0,6
1991,"Identification of a functionally conserved surface region of rat cytochromes P450IA","Edwards R.J., Singleton A.M., Murray B.P., Murray S., Boobis A.R., Davies D.S.",02646021,"Biochemical Journal",278, 3,12,0,0,0,1,13
1991,"Combined assay for phenacetin and paracetamol in plasma using capillary column gas chromatography-negative-ion mass spectrometry","Murray S., Boobis A.R.",03784347,"Journal of Chromatography - Biomedical Applications",568, 2,11,1,2,3,1,15
1991,"Mechanisms of cell death","Fawthrop D.J., Boobis A.R., Davies D.S.",03405761,"Archives of Toxicology",65, 6,99,3,4,7,4,110
1991,"Inducible bilirubin-degrading system of rat liver microsomes: Role of cytochrome P450IA1","De Matteis F., Dawson S.J., Boobis A.R., Comoglio A.",0026895X,"Molecular Pharmacology",40, 5,24,0,0,0,0,24
1991,"Pharmacogenetics","Boobis A.R., Murray B.P.",10408703,"Current Opinion in Pediatrics",3, 2,0,0,0,0,0,0
1991,"The measurement of MeIQx adducts with mouse haemoglobin in vitro and in vivo: Implications for human dosimetry","Lynch A.M., Murray S., Boobis A.R., Davies D.S., Gooderham N.J.",01433334,"Carcinogenesis",12, 6,8,0,0,0,1,9
1991,"Phenotype or genotype?","Jackson P.R., Boobis A.R., Tucker G.T.",03065251,"British Journal of Clinical Pharmacology",31, 1,1,0,0,0,0,1
1990,"Species variation in the response of the cytochrome P-450-dependent monooxygenase system to inducers and inhibitors","Boobis A.R., Pelkonen O., Pasanen M., Kobayashi S., Zhi-Guang T., Davies D.S., Sesardic D., Murray B.P., Edwards R.J., Singleton A.M., Rich K.J., Murray S., De la Torre R., Segura J.",00498254,"Xenobiotica",20, 11,75,1,0,1,1,77
1990,"Assay of caffeine metabolism in vitro by human liver microsomes using radio-high-performance liquid chromatography","Valero F., De La Torre R., Boobis A.R., Murray S., Segura J.",07317085,"Journal of Pharmaceutical and Biomedical Analysis",8, 8-12,1,0,0,0,0,1
1990,"Mutagenesis of mouse intestine in vivo using the Dlb-1 specific locus test: Studies with 1,2-dimethylhydrazine, dimethylnitrosamine, and the dietary mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline","Winton D.J., Gooderham N.J., Boobis A.R., Davies D.S., Ponder B.A.J.",00085472,"Cancer Research",50, 24,19,0,0,0,0,19
1990,"Ontogeny of expression, distribution and inducibility of cytochromes P450IA1 and IA2 in hepatic and extrahepatic tissues of the rat","Boobis A.R., Edwards R.J., Foster J.R., Rich K.J.",00142999,"European Journal of Pharmacology",183, 4,1,0,0,0,0,1
1990,"Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man","Sesardic D., Boobis A.R., Murray B.P., Murray S., Segura J., De La Torre R., Davies D.S.",03065251,"British Journal of Clinical Pharmacology",29, 6,153,6,9,15,3,171
1990,"Mechanisms of cell toxicity","Boobis A.R., Fawthrop D.J., Davies D.S.",09550674,"Current Opinion in Cell Biology",2, 2,10,0,1,1,0,11
1990,"Evidence for a direct role of intracellular calcium in paracetamol toxicity","Boobis A.R., Seddon C.E., Nasseri-Sina P., Davies D.S.",00062952,"Biochemical Pharmacology",39, 8,12,0,0,0,0,12
1990,"Evidence that a ?-N-glucuronide of 4,4'-methylenebis(2-chloroaniline) (MbOCA) is a major urinary metabolite in man: implications for biological monitoring","Cooker J., Boobis A.R., Wilson H.K., Gompertz D.",00071072,"British Journal of Industrial Medicine",47, 3,10,0,0,0,0,10
1990,"An anti-peptide antibody targeted to a specific region of rat cytochrome P-450IA2 inhibits enzyme activity","Edwards R.J., Singleton A.M., Murray B.P., Sesardic D., Rich K.J., Davies D.S., Boobis A.R.",02646021,"Biochemical Journal",266, 2,14,0,0,0,1,15
1990,"The inducibility and catalytic activity of cytochromes P450c (P450IA1) and P450d (P450IA2) in rat tissues","Sesardic D., Cole K.J., Edwards R.J., Davies D.S., Thomas P.E., Levin W., Boobis A.R.",00062952,"Biochemical Pharmacology",39, 3,29,0,1,1,0,30
1990,"High affinty phenacetin O-deethylase is catalysed specifically by cytochrome P450d (P450IA2) in the liver of the rat","Sesardic D., Edwards R.J., Davies D.S., Thomas P.E., Levin W., Boobis A.R.",00062952,"Biochemical Pharmacology",39, 3,27,0,1,1,0,28
1990,"Debrisoquine oxidation phenotype and susceptibility to lung cancer","Boobis A.R., Davies D.S.",03065251,"British Journal of Clinical Pharmacology",30, 4,1,0,0,0,0,1
1990,"Exposure to, and activation of, the food derived mutagenic heterocyclic amine MeIQx.","Gooderham N.J., Murray B.P., Murray S., Boobis A.R., Davies D.S.",03617742,"Progress in clinical and biological research",340, ,1,0,0,0,0,1
1990,"Tissue selective expression and inducibility of members of the cytochrome P450IA family in man","Boobis A.R., Sesardic D., Pasanen M., Pelkonen O., Segura J., Davies D.S.",03065251,"British Journal of Clinical Pharmacology",29, 5,0,0,0,0,0,0
1990,"Rapid tolerance to the hypotensive effects of glyceryl trinitrate in the rat: Prevention by N-acetyl-L- but not N-acetyl-D-cysteine","Newman C.M., Warren J.B., Taylor G.W., Boobis A.R., Davies D.S.",00071188,"British Journal of Pharmacology",99, 4,10,0,0,0,1,11
1990,"Differential expression and regulation of members of the cytochrome P450IA gene subfamily in human tissues","Sesardic D., Pasanen M., Pelkonen O., Boobis A.R.",01433334,"Carcinogenesis",11, 7,61,4,2,6,0,67
1990,"Debrisoquine oxidation phenotype and susceptibility to lung cancer","Speirs C.J., Murray S., Davies D.S., Biola Mabadeje A.F., Boobis A.R.",03065251,"British Journal of Clinical Pharmacology",29, 1,13,0,0,0,0,13
1989,"Species differences in specificity of hydrocarbon-inducible forms of cytochrome P-450","Murray B.P., Sesardic D., Davies D.S., Boobis A.R.",03005127,"Biochemical Society Transactions",17, 6,0,0,0,0,0,0
1989,"Identification of surface regions of cytochromes P-450 using anti-peptide antibodies","Edwards R.J., Murray B.P., Singleton A.M., Davies D.S., Boobis A.R.",03005127,"Biochemical Society Transactions",17, 6,0,0,0,0,0,0
1989,"Identification and location of ?-helices in mammalian cytochromes P450","Edwards R.J., Murray B.P., Boobis A.R., Davies D.S.",00062960,"Biochemistry",28, 9,26,0,0,0,0,26
1989,"Ontogeny of expression, inducibility and distribution of cytochromes P-450 forms 4 and 6 in rabbit liver","Rich K.J., Edwards R.J., Foster J.R., Davies D.S., Boobis A.R.",03005127,"Biochemical Society Transactions",17, 6,0,0,0,0,0,0
1989,"Dietary heterocyclic amines and human cancer","Gooderham N.J., Murray S., Rice J.C., Boobis A.R., Davies D.S.",03602532,"Drug Metabolism Reviews",20, 2-4,4,0,0,0,0,4
1989,"Cross-reaction of antibodies to coupling groups used in the production of anti-peptide antibodies","Edwards R.J., Singleton A.M., Boobis A.R., Davies D.S.",00221759,"Journal of Immunological Methods",117, 2,9,2,0,2,0,11
1989,"Relevance of genetic polymorphism in drug metabolism in the development of new drugs","Balant L.P., Gundert-Remy U., Boobis A.R., Von Bahr Ch.",00316970,"European Journal of Clinical Pharmacology",36, 6,11,0,0,0,0,11
1989,"Effects of nortriptyline on the activities of human and rat liver microsome bufuralol 1'-hydroxylase in vitro","Tu Z.-G., Seddon C.E., Boobis A.R., Davies D.S.",02539756,"Acta Pharmacologica Sinica",10, 5,1,0,0,0,0,1
1989,"The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man","Kobayashi S., Murray S., Watson D., Sesardic D., Davies D.S., Boobis A.R.",00062952,"Biochemical Pharmacology",38, 17,82,0,2,2,1,85
1989,"Mechanisms of cell death","Boobis A.R., Fawthrop D.J., Davies D.S.",01656147,"Trends in Pharmacological Sciences",10, 7,75,0,0,0,1,76
1989,"Detection and measurement of MeIQx in human urine after ingestion of a cooked meat meal","Murray S., Gooderham N.J., Boobis A.R., Davies D.S.",01433334,"Carcinogenesis",10, 4,52,0,1,1,0,53
1989,"Immunohistochemical localization of cytochrome P450b/e in hepatic and extrahepatic tissues of the rat","Rich K.J., Sesardic D., Foster J.R., Davies D.S., Boobis A.R.",00062952,"Biochemical Pharmacology",38, 19,25,0,1,1,0,26
1989,"Selective destruction of cytochrome P-450d and associated monooxygenase activity by carbon tetrachloride in the rat","Sesardic D., Rich K.J., Edwards R.J., Davies D.S., Boobis A.R.",00498254,"Xenobiotica",19, 7,7,0,0,0,0,7
1989,"Activation of the food carcinogen 2-amino-3,8-dimethylimidazo[4,5 f]quinoxaline by hepatocytes","Gooderham N.J., Rice J.C., Nasseri-Sina P., Boobis A.R., Davies D.S.",03005127,"Biochemical Society Transactions",17, 4,0,0,0,0,0,0
1988,"Time course of inhibition by quinidine of debrisoquine 4-hydroxylase activity in man","Kobayashi S., Speirs C.J., Watson D., Murray S., Sesardic D., Boobis A.R.",03065251,"British Journal of Clinical Pharmacology",25, 5,1,0,0,0,0,1
1988,"Cytoprotective effects of 16,16-dimethyl prostaglandin E2 on paracetamol toxicity in isolated hepatocytes","Nasseri-Sina P., Seddon C.E., Boobis A.R., Davies D.S.",03005127,"Biochemical Society Transactions",16, 4,1,0,0,0,0,1
1988,"A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking","Sesardic D., Boobis A.R., Edwards R.J., Davies D.S.",03065251,"British Journal of Clinical Pharmacology",26, 4,114,4,6,10,4,128
1988,"Determination of the N-acetyl metabolites of 4,4'-methylene dianiline and 4,4'-methylene-bis(2-chloroaniline) in urine","Cocker J., Boobis A.R., Davies D.S.",08876134,"Biomedical and Environmental Mass Spectrometry",17, 3,15,2,2,4,0,19
1988,"Immunohistochemical localization of cytochrome P-450 b/e in hepatic and extrahepatic rat tissues","Rich K.J., Boobis A.R., Foster J.R., Sesardic D., Davies D.S.",03005127,"Biochemical Society Transactions",16, 4,0,0,0,0,0,0
1988,"Inhibition of dietary mutagen activition by methylxanthines","Murray B.P., Boobis A.R., De La Torre R., Segura J., Davies D.S.",03005127,"Biochemical Society Transactions",16, 4,4,0,0,0,0,4
1988,"Quinidine discriminates between rat and human debrisoquine 4-hydroxylase","Zhi-Guang T., Murray B., Sesardic D., Kobayashi S., Murray S., Davies D.S., Boobis A.R.",03065251,"British Journal of Clinical Pharmacology",25, 5,4,0,0,0,0,4
1988,"Antibodies to a synthetic peptide that react specifically with a common surface region on two hydrocarbon-inducible isoenzymes of cytochrome P-450 in the rat","Edwards R.J., Singleton A.M., Sesardic D., Boobis A.R., Davies D.S.",00062952,"Biochemical Pharmacology",37, 19,20,0,0,0,0,20
1988,"Hepatotoxicity of carbon tetrachloride: Protection by pretreatment of mice with polyriboinosine acid·polyribocytidylic acid","Freeman A., Boobis A.R., Gooderham N.J.",03005127,"Biochemical Society Transactions",16, 4,0,0,0,0,0,0
1988,"Measurement of MeIQx and DiMeIQx in fried beef by capillary column gas chromatography electron capture negative ion chemical ionisation mass spectrometry","Murray S., Gooderham N.J., Boobis A.R., Davies D.S.",01433334,"Carcinogenesis",9, 2,39,0,2,2,0,41
1988,"An assay for 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline and 2-amino-3,4,8-trimethylimidazo[4,5-f]quinoxaline in fried beef using capillary column gas chromatography electron capture negative ion chemical ionization mass spectrometry","Murray S., Gooderham N.J., Boobis A.R., Davies D.S.",08876134,"Biomedical and Environmental Mass Spectrometry",16, 1-12,0,0,0,0,0,0
1987,"Guanethidine N-oxidation in human liver microsomes","McManus M.E., Davies D.S., Boobis A.R., Grantham P.H., Wirth P.J.",00223573,"Journal of Pharmacy and Pharmacology",39, 12,3,0,0,0,0,3
1987,"Phenacetin O-deethylase activity of the rat: Strain differences and the effects of enzyme-inducing compounds","Kahn G.C., Rubenfield M., Davies D.S., Boobis A.R.",00498254,"Xenobiotica",17, 2,3,0,0,0,0,3
1987,"Species differences in the hepatotoxicity of paracetamol are due to differences in the rate of conversion to its cytotoxic metabolite","Tee L.B.G., Davies D.S., Seddon C.E., Boobis A.R.",00062952,"Biochemical Pharmacology",36, 7,23,1,3,4,3,30
1987,"Strain differences in the metabolic activation of aflatoxin B1 in the rat","Plummer S., Boobis A.R., Davies D.S.",00498254,"Xenobiotica",17, 2,5,0,0,0,0,5
1987,"In vitro studies of induction and inhibition of drug oxidation in man","Boobis A.R., Murray S., Seddon C.E., Davies D.S.",01637258,"Pharmacology and Therapeutics",33, 1,1,0,0,0,1,2
1986,"Freshly isolated hepatocytes as a model for studying the toxicity of paracetamol","Boobis A.R., Tee L.B.G., Hampden C.E., Davies D.S.",02786915,"Food and Chemical Toxicology",24, 6-7,8,3,0,3,0,11
1986,"Quinidine and the identification of drugs whose elimination is impaired in subjects classified as poor metabolizers of debrisoquine","Speirs C.J., Murray S., Boobis A.R.",03065251,"British Journal of Clinical Pharmacology",22, 6,23,0,0,0,1,24
1986,"Induction of mixed function oxidase activity in man by rifapentine (MDL 473), a long-acting rifamycin derivative","Durand D.V., Hampden C., Boobis A.R.",03065251,"British Journal of Clinical Pharmacology",21, 1,12,0,0,0,0,12
1986,"Comparative activation of aromatic amines to mutagenic metabolites by human and rat liver","Harries G.C., Boobis A.R., Sesardic D.",02786915,"Food and Chemical Toxicology",24, 6-7,0,0,0,0,0,0
1986,"Immunocytochemical localization of cytochrome P-450 in hepatic and extra-hepatic tissues of the rat with a monoclonal antibody against cytochrome P-450 c","Foster J.R., Elcombe C.R., Boobis A.R.",00062952,"Biochemical Pharmacology",35, 24,24,0,0,0,2,26
1986,"Routes of activation of 4,4'-methylenebis-(2-chloroaniline) and 4,4'-methylenedianiline to bacterial mutagens","Cocker J., Boobis A.R., Davies D.S.",02786915,"Food and Chemical Toxicology",24, 6-7,3,0,1,1,0,4
1986,"Is the activation of aflatoxin B1 catalysed by the same form of cytochrome P-450 as that 4-hydroxylating debrisoquine in rat and/or man?","Plummer S., Boobis A.R., Davies D.S.",03405761,"Archives of Toxicology",58, 3,2,0,0,0,0,2
1986,"Interindividual differences in the activation of two hepatic carcinogens to mutagens by human liver","Harries G.C., Boobis A.R., Collier N., Davies D.S.",01445952,"Human Toxicology",5, 1,0,0,0,0,0,0
1986,"Reversal of acetaminophen toxicity in isolated hamster hepatocytes by dithiotreitol","Tee L.B.G., Boobis A.R., Huggett A.C., Davies D.S.",0041008X,"Toxicology and Applied Pharmacology",83, 2,18,1,2,3,1,22
1986,"An assay for paracetamol, produced by the O-deethylation of phenacetin in vitro, using gas chromatography/electron capture negative ion chemical ionization mass spectrometry","Murray S., Boobis A.R.",0306042X,"Biomedical Mass Spectrometry",13, 2,8,0,0,0,0,8
1986,"Bufuralol 1'-hydroxylase activity of the rat. Strain differences and the effects of inhibitors","Boobis A.R., Seddon C.E., Davies D.S.",00062952,"Biochemical Pharmacology",35, 17,13,1,0,1,0,14
1986,"Inter-relatedness of some isoenzymes of cytochrome P-450 from rat, rabbit and human, determined with monoclonal antibodies","Sesardic D., Boobis A.R., McQuade J.",02646021,"Biochemical Journal",236, 2,2,0,0,0,0,2
1986,"N-acetylcysteine for paracetamol overdose","Tee L.G.B., Boobis A.R., Davies D.S.",01406736,"Lancet",1, 8476,5,0,0,0,1,6
1986,"Acetaminophen toxicity in isolated hepatocytes.","Davies D.S., Tee L.B., Hampden C., Boobis A.R.",00652598,"Advances in experimental medicine and biology",197, ,1,0,1,1,0,2
1986,"Flavin-containing monooxygenase activity in human liver microsomes.","McManus M.E., Thorgeirsson S.S., Birkett D.J., Burgess W.M., Stupans I., Koenig J.A., Boobis A.R., Davies D.S., Wirth P.J., Grantham P.H.",00652598,"Advances in experimental medicine and biology",197, ,2,0,0,0,0,2
1986,"Selective induction and inhibition of the components of 7-ethoxycoumarin O-deethylase activity in the rat","Boobis A.R., Whyte C., Davies D.S.",00498254,"Xenobiotica",16, 3,9,0,1,1,0,10
1985,"Drug metabolising activity of freshly isolated human hepatocytes","Tee L.B.G., Seddon T., Boobis A.R., Davies D.S.",03065251,"British Journal of Clinical Pharmacology",19, 3,6,0,0,0,0,6
1985,"Polymorphic metabolism of the carcinogen 2-acetylaminofluorene in human liver microsomes","Minchin R.F., McManus M.E., Boobis A.R.",01433334,"Carcinogenesis",6, 12,9,0,1,1,0,10
1985,"A monoclonal antibody raised to rat liver cytochrome P-448 (form c) which recognises an epitope common to many other forms of cytochrome P-450","Boobis A.R., McQuade J., Sesardic D.",00062952,"Biochemical Pharmacology",34, 10,4,0,0,0,0,4
1985,"Antipyrine elimination in patients with obstructive jaundice: A predictor of outcome","McPherson G.A.D., Benjamin I.S., Boobis A.R., Blumgart L.H.",00029610,"American Journal of Surgery",149, 1,7,0,0,0,0,7
1985,"Phenacetin O-deethylase: An activity of a cytochrome P-450 showing genetic linkage with that catalysing the 4-hydroxylation of debrisoquine?","Kahn G.C., Boobis A.R., Brodie M.J.",03065251,"British Journal of Clinical Pharmacology",20, 1,5,0,0,0,0,5
1985,"The metabolic activation of 4,4'-methylene-bis-(2-chlorobenzeneamine) to a bacterial mutagen by hepatic postmitochondrial supernatant from human and other species","Cocker J., Boobis A.R., Gibson J.F., Davies D.S.",01922521,"Environmental Mutagenesis",7, 4,0,0,0,0,0,0
1985,"Genetic polymorphism in drug oxidation: In vitro studies of human debrisoquine 4-hydroxylase and bufuralol 1'-hydroxylase activities","Boobis A.R., Murray S., Hampden C.E., Davies D.S.",00062952,"Biochemical Pharmacology",34, 1,12,0,0,0,1,13
1985,"Attempts to phenotype human liver samples in vitro for debrisoquine 4-hydroxylase activity","Boobis A.R., Hampden C.E., Murray S.",03065251,"British Journal of Clinical Pharmacology",19, 6,2,0,0,0,0,2
1985,"Separation of acebutolol and diacetolol diastereomers by reversed-phase high-performance liquid chromatography","Gulaid A.A., Houghton G.W., Boobis A.R.",,"Journal of Chromatography",318, 2,5,0,0,0,0,5
1984,"Relationship between oxidative metabolism of 2-acetylaminofluorene, debrisoquine, bufuralol, and aldrin in human liver microsomes","McManus M.E., Boobis A.R., Minchin R.F.",00085472,"Cancer Research",44, 12 I,0,0,0,0,0,0
1984,"Species differences in the hepatic formation of green pigments following the administration of norethindrone","White I.N.H., Boobis A.R., Davies D.S.",00062952,"Biochemical Pharmacology",33, 3,0,0,0,0,0,0
1984,"Human cytochrome P-450","Boobis A.R., Davies D.S.",00498254,"Xenobiotica",14, 1-2,12,0,0,0,0,12
1984,"Multiple forms of human cytochrome P-450","Boobis A.R., Davies D.S.",03005127,"Biochemical Society Transactions",12, 1,1,0,0,0,0,1
1983,"Variants of human microsomal enzymes","Davies D.S., Boobis A.R.",03005127,"Biochemical Society Transactions",11, 4,0,0,0,0,0,0
1983,"Molecular aspects of debrisoquine metabolism studied by gas chromatography mass spectrometry with electron capture negative ion chemical ionisation","Murray S., Kahh G.C., Boobis A.R., Davies D.S.",00207381,"International Journal of Mass Spectrometry and Ion Physics",48, C,0,0,0,0,0,0
1983,"Substrate specificity of the form of cytochrome P-450 catalyzing the 4-hydroxylation of debrisoquine in man","Boobis A.R., Murray S., Kahn G.C.",0026895X,"Molecular Pharmacology",23, 2,7,0,4,4,0,11
1982,"Assay and characterisation of debrisoquine 4-hydroxylase activity of microsomal fractions of human liver","Kahn G.C., Boobis A.R., Murray S.",03065251,"British Journal of Clinical Pharmacology",13, 5,17,0,1,1,0,18
1982,"Altered pharmacokinetics","Boobis A.R., Lewis P.",00071064,"British Journal of Hospital Medicine",28, 6,3,1,0,1,0,4
1982,"Tissue differences in the ontogeny of inducibility of drug-metabolizing enzymes by 3-methylcholanthrene in the rabbit","Pacifici G.M., Davies D.S., Whyte C., Boobis A.R.",00498254,"Xenobiotica",12, 9,1,0,0,0,0,1
1982,"Effect of rifampicin and isoniazid on vitamin D metabolism","Brodie M.J., Boobis A.R., Hillyard C.J.",00099236,"Clinical Pharmacology and Therapeutics",32, 4,14,1,3,4,3,21
1982,"Immunopurification of cytochrome P-448 from microsomal fractions of rabbit liver with retention of metabolic activity","Lewis K.M., Boobis A.R., Slade M.B., Davies D.S.",00062952,"Biochemical Pharmacology",31, 9,0,0,0,0,0,0
1982,"Differential effects of 3-methylcholanthrene and phenobarbitone treatment on the oxidative metabolism of antipyrine in vitro by microsomal fractions of rat liver","Kahn G.C., Boobis A.R., Murray S., Davies D.S.",00498254,"Xenobiotica",12, 8,3,0,0,0,0,3
1982,"Antipyrine elimination as a dynamic test of hepatic functional integrity in obstructive jaundice","McPherson G.A.D., Benjamin I.S., Boobis A.R.",00175749,"Gut",23, 9,8,0,1,1,0,9
1981,"Differential induction of antipyrine metabolism by rifampicin","Toverud E.-L., Boobis A.R., Brodie M.J.",00316970,"European Journal of Clinical Pharmacology",21, 2,3,0,0,0,0,3
1981,"A radiometric high-pressure liquid chromatography assay for the simultaneous determination of the three main oxidative metabolites of antipyrine in studies in vitro","Kahn C., Boobis A.R., Blair I.A.",00032697,"Analytical Biochemistry",113, 2,3,0,0,0,0,3
1981,"Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man","Boobis A.R., Brodie M.J., Kahn G.C.",03065251,"British Journal of Clinical Pharmacology",12, 6,7,1,0,1,0,8
1981,"Metabolism and mutagenic activation of 2-acetylaminofluorene by human liver and lung.","Boobis A.R., Brodie M.J., McManus M.E., Staiano N., Thorgeirsson S.S., Davies D.S.",00652598,"Advances in Experimental Medicine and Biology",136, ,1,0,0,0,0,1
1981,"Monoclonal antibodies to rabbit liver cytochrome P-448","Boobis A.R., Slade M.B., Stern C.",00243205,"Life Sciences",29, 14,2,0,0,0,0,2
1981,"Influence of liver disease and environmental factors on hepatic monooxygenase activity in vitro","Brodie M.J., Boobis A.R., Bulpitt C.J., Davies D.S.",00316970,"European Journal of Clinical Pharmacology",20, 1,19,0,0,0,0,19
1981,"The selective activation of cytochrome P-450 dependent microsomal hydroxylases in human and rat liver microsomes","Benford D.J., Bridges J.W., Boobis A.R.",00062952,"Biochemical Pharmacology",30, 12,0,0,0,0,0,0
1981,"Does rifampicin increase serum levels of testosterone and oestradiol by inducing sex hormone binding globulin capacity?","Brodie M.J., Boobis A.R., Gill M., Mashiter K.",03065251,"British Journal of Clinical Pharmacology",12, 3,5,0,0,0,0,5
1981,"Biphasic O-deethylation of phenacetin and 7-ethoxycoumarin by human and rat liver microsomal fractions","Boobis A.R., Kahn G.C., Whyte C.",00062952,"Biochemical Pharmacology",30, 17,28,0,0,0,0,28
1981,"Inhibition by isoniazid of vitamin D metabolism in man","Brodie M.J., Boobis A.R., Hillyard C.J.",03065251,"British Journal of Clinical Pharmacology",11, 4,0,0,0,0,0,0
1981,"Comparison of in vivo and in vitro rates of antipyrine oxidation in man","Boobis A.R., Brodie M.J., Kahn G.C.",03065251,"British Journal of Clinical Pharmacology",11, 4,0,0,0,0,0,0
1981,"Tissue and species differences in enzymes of epoxide metabolism","Pacifici G.M., Boobis A.R., Brodie M.J.",00498254,"Xenobiotica",11, 2,10,0,0,0,0,10
1981,"Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity","Brodie M.J., Boobis A.R., Hillyard C.J.",00099236,"Clinical Pharmacology and Therapeutics",30, 3,7,0,1,1,0,8
1980,"Xenobiotic metabolism in the human lung","McManus M.E., Boobis A.R., Pacifici G.M.",00243205,"Life Sciences",26, 6,9,0,0,0,0,9
1980,"Catecholamine turnover in essential hypertension.","Reid J.L., Jones D.H., Fitzgerald G., Davies D., Boobis A.",01483927,"Clinical and experimental hypertension",2, 3-4,0,0,0,0,0,0
1980,"Paracetamol oxidation: synthesis and reactivity of N-acetyl-p-benzoquinoneimine","Blair I.A., Boobis A.R., Davies D.S., Cresp T.M.",00404039,"Tetrahedron Letters",21, 51,5,1,0,1,0,6
1980,"Drug metabolism in white vegetarians","Brodie M.J., Boobis A.R., Toverud E.L.",03065251,"British Journal of Clinical Pharmacology",9, 5,3,0,0,0,0,3
1980,"Urinary conjugates of 4-hydroxy-3-methoxyphenylethylene glycol do not provide an index of brain amine turnover in man","Boobis A.R., Murray S., Jones D.H.",01435221,"Clinical Science",58, 4,1,1,0,1,0,2
1980,"Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens","Boobis A.R., Brodie M.J., Kahn G.C.",03065251,"British Journal of Clinical Pharmacology",9, 1,31,1,0,1,1,33
1980,"Rifampicin and vitamin D metabolism in man","Brodie M.J., Boobis A.R., Dollery C.T.",03065251,"British Journal of Clinical Pharmacology",9, 3,1,0,0,0,0,1
1980,"Rifampicin and vitamin D metabolism","Brodie M.J., Boobis A.R., Dollery C.T.",00099236,"Clinical Pharmacology and Therapeutics",27, 6,10,0,4,4,0,14
1980,"Stereoselective excretion of 3-methoxy-4-hydroxyphenylethylene glycol sulphate in the dog","Baillie T.A., Boobis A.R., Davies D.S.",00071188,"British Journal of Pharmacology",69, 2,0,0,0,0,0,0
1980,"Antipyrine as an in vitro probe of mixed function oxidase activity","Kahn G.C., Boobis A.R., Blair I.",03065251,"British Journal of Clinical Pharmacology",9, 3,0,0,0,0,0,0
1980,"Developmental changes in the inducibility of drug metabolising enzymes by 3-methylcholanthrene in hepatic and extrahepatic tissues of the rabbit","Boobis A.R., Davies D.S., Pacifici G.M.",00071188,"British Journal of Pharmacology",69, 2,0,0,0,0,0,0
1980,"DNA binding of benzo[a]pyrene metabolites. Effects of substrate and microsomal protein concentration in vitro. Dietary contaminants, and tissue differences","Legraverend C., Nebert D.W., Boobis A.R., Pelkonen O.",00317012,"Pharmacology",20, 3,1,0,0,0,0,1
1980,"Stereoselective excretion of (3-methoxy-4-sulphooxyphenyl)ethylene glycol (MHPG sulphate) in the dog","Murray S., Boobis A.R., Frank H.",00281298,"Naunyn-Schmiedeberg's Archives of Pharmacology",314, 1,1,0,0,0,0,1
1979,"Genetic differences in the metabolic activation of benzo[a]pyrene in mice. Attempts to correlate tumorigenesis with binding of reactive intermediates to DNA and with mutagenesis in vitro","Pelkonen O., Boobis A.R., Levitt R.C.",00317012,"Pharmacology",18, 6,4,0,0,0,0,4
1979,"Effects of microsomal enzyme inducers in vivo and inhibitors in vitro on the covalent binding of benzo[a]pyrene metabolites to DNA catalyzed by liver microsomes from genetically responsive and nonresponsive mice","Boobis A.R., Nebert D.W., Pelkonen O.",00062952,"Biochemical Pharmacology",28, 1,0,0,0,0,0,0
1979,"Developmental pharmacology and the Ah locus: Regulatory and temporal genes affecting teratogenesis","Nebert D.W., Shum S., Boobis A.R., Atlas S.A.",00015318,"Acta Biologica et Medica Germanica",38, 4,0,0,0,0,0,0
1979,"A rapid sensitive assay for glutathione S-epoxidetransferase activity: species differences in the activity of the hepatic enzyme [proceedings]","Pacifici G.M., Boobis A.R., Brodie M.J., Davies D.S.",03005127,"Biochemical Society Transactions",7, 5,0,0,0,0,0,0
1979,"Environmental factors affecting monooxygenase activity of microsomal fractions of human liver biopsies","Boobis A.R., Brodie M.J., Bulpitt C.J., Davies D.S.",00071188,"British Journal of Pharmacology",66, 3,0,0,0,0,0,0
1979,"Biphasic Michaelis-Menten kinetics for ethoxycoumarin and phenacetin metabolism by human and rat hepatic monooxygenases","Boobis A.R., Brodie M.J., Davies D.S.",00071188,"British Journal of Pharmacology",66, 3,0,0,0,0,0,0
1979,"Genetic differences in the binding of benzo[a]pyrene metabolites to DNA in the mouse","Boobis A.R., Kouri R.E., Nebert D.W.",0361090X,"Cancer Detection and Prevention",2, 1,0,0,0,0,0,0
1979,"Resolution and reconstitution of two forms of hepatic cytochrome P-450 from rabbits","Boobis A.R., Davies D.S., Lewis K.M.",00071188,"British Journal of Pharmacology",66, 3,0,0,0,0,0,0
1979,"Substrate-metabolite profiles in the study of inter-individual differences in drug oxidation in man","Boobis A.R., Brodie M.J., Davies D.S.",03065251,"British Journal of Clinical Pharmacology",7, 4,0,0,0,0,0,0
1979,"Species differences in the substrate specificity of hepatic cytochrome P-448 from polycyclic hydrocarbon treated animals","Thorgeirsson S.S., Atlas S.A., Boobis A.R., Felton J.S.",00062952,"Biochemical Pharmacology",28, 2,6,0,0,0,0,6
1978,"Carcinogenic benzo(a)pyrene metabolites bound to DNA: Metabolic formation by human cultured lymphocytes and by human liver microsomes","Boobis A.R., Atlas S.A., Nebert D.W.",00317012,"Pharmacology",17, 5,1,0,0,0,0,1
1978,"Mixed function oxidase activity in microsomal fractions of human liver biopsy specimens","Boobis A.R., Brodie M.J., Davies D.S.",03065251,"British Journal of Clinical Pharmacology",6, 5,0,0,0,0,0,0
1978,"Tentative identification of benzo(a)pyrene metabolite-nucleoside complexes produced in vitro by mouse liver microsomes","Pelkonen O., Boobis A.R., Yagi H.",0026895X,"Molecular Pharmacology",14, 2,1,0,0,0,0,1
1977,"Induction of aryl hydrocarbon (benzo[a]pyrene) hydroxylase and 2 acetylaminofluorene n hydroxylase by polycyclic hydrocarbons in regenerating liver from inbred strains of mice","Boobis A.R., Reinhold C., Thorgeirsson S.S.",00062952,"Biochemical Pharmacology",26, 16,0,0,0,0,0,0
1977,"Ontogenetic expression of polycyclic aromatic compound inducible monooxygenase activities and forms of cytochrome P 450 in rabbit. Evidence for temporal control and organ specificity of two genetic regulatory systems","Atlas S.A., Boobis A.R., Felton J.S.",00219258,"Journal of Biological Chemistry",252, 13,10,0,0,0,0,10
1977,"Comparison of ? naphthoflavone and 3 methylcholanthrene as inducers of hepatic cytochrome(s) P 448 and aryl hydrocarbon (benzo[a]pyrene) hydroxylase activity","Boobis A.R., Nebert D.W., Felton J.S.",0026895X,"Molecular Pharmacology",13, 2,24,0,0,0,0,24
1977,"Genetic differences in the metabolism of carcinogens and in the binding of benzo[a]pyrene metabolites to DNA","Boobis A.R., Nebert D.W.",00652571,"Advances in Enzyme Regulation",15, C,0,0,0,0,0,0
1977,"Studies on the metabolic fate of 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) in man","Baillie T.A., Boobis A.R., Davies D.S.",00071188,"British Journal of Pharmacology",60, 2,0,0,0,0,0,0
1976,"Induction and inhibition of the formation of benzo[a]pyrene metabolites that covalently bind to DNA by inbred mice","Boobis A.R., Nebert D.W.",00317004,"Pharmacologist",18, 2,0,0,0,0,0,0
1976,"Comparison of mouse hepatic aryl hydrocarbon hydroxylase induction by 3 methylcholanthrene and ? naphthoflavone","Boobis A.R., Felton J.S.",00149446,"Federation Proceedings",35, 3,0,0,0,0,0,0
1976,"Genetic differences in carcinogenic index of benzo[a]pyrene in vivo and binding of its metabolites to DNA in vitro","Boobis A.R., Nebert D.W.",,"Proceedings of the American Association for Cancer Research",17, ,0,0,0,0,0,0
1976,"Binding of benzo(a)pyrene metabolites to DNA in vitro catalyzed by human lymphocytes","Boobis A.R., Nebert D.W., Atlas S.A.",00099279,"Clinical Research",24, 3,0,0,0,0,0,0
1975,"Varying substrate specificities of cytochrome P1450 in polycyclic hydrocarbon treated animals of five species","Thorgeirsson S.S., Atlas S.A., Boobis A.R.",00317004,"Pharmacologist",17, 2,0,0,0,0,0,0
1975,"Induction by polycyclic hydrocarbons of aryl hydrocarbon (benzo[a]pyrene) hydroxylase in regenerating liver of inbred strains of mice","Boobis A.R., Reinhold C., Thorgeirsson S.S.",00317004,"Pharmacologist",17, 2,0,0,0,0,0,0
1975,"Effect of washing the hepatic microsomal fraction in sucrose solutions and in sucrose solution containing EDTA upon the metabolism of foreign compounds","Powis G., Boobis A.R.",00062952,"Biochemical Pharmacology",24, 19,3,0,0,0,0,3
1975,"Differential induction of murine Ah locus associated monooxygenase activities in rabbit liver and kidney","Atlas S.A., Thorgeirsson S.S., Boobis A.R.",00062952,"Biochemical Pharmacology",24, 22,0,0,0,0,0,0
1975,"The metabolism and disposition of aniline in the isolated blood-perfused liver of the rat.","Boobis A.R., Powis G.",00909556,"Drug Metabolism and Disposition",3, 2,0,0,0,0,0,0
1975,"Ethanol protection against hemicholinium toxicity in mice","Boobis A.R., Gibson A., Stevenson R.W.",00062952,"Biochemical Pharmacology",24, 4,1,0,0,0,0,1
1975,"The effect of pretreating rats with 3-methylcholanthrene upon the enhancement of microsomal aniline hydroxylation by acetone and other agents","Powis G., Boobis A.R.",00062952,"Biochemical Pharmacology",24, 3,1,0,0,0,0,1
1974,"The effects of catecholamines upon the metabolism of foreign compounds and upon the distribution of perfusate in the isolated liver of the rat","Boobis A.R., Powis G.",00062952,"Biochemical Pharmacology",23, 24,3,0,0,0,0,3
1973,"The isolated perfused rat liver in the study of the metabolism of foreign compounds","Boobis A., Powis G.",,"BRIT.J.PHARMACOL.",49, 1,0,0,0,0,0,0
1971,"Influence of phenobarbitone on liver regeneration and microsomal N-demethylating activity in partially hepatectomized rats.","Boobis A.R., Pollock D., Gillespie J.S.",00071188,"British Journal of Pharmacology",43, 2,1,0,0,0,0,1
